OXOMEMAZINE CRISTERS 0.33 mg/ml sugar-free, oral solution sweetened with acesulfame potassium in a vial bottle, 150 ml
Active ingredients: Oxomemazine
Commercialized according to BDPM
Oral solutionbottle, 150 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OXOMEMAZINE CRISTERS 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l’acésulfame potassique en flacon
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre de 150 ml avec gobelet(s) doseur(s) polypropylène
- Marketing authorisation holder
- CRISTERS
- Reimbursement according to BDPM
- 15 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Nov 2020
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65340100CIP73008181CIP133400930081815Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OXOMÉMAZINEsolution | 0,033 g · 100 ml de solution buvable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.